 |
PDBsum entry 4x0r
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Antiviral protein
|
PDB id
|
|
|
|
4x0r
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochem Biophys Res Commun
456:197-201
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insight into the assembly of human anti-HIV dynamin-like protein MxB/Mx2.
|
|
B.Xu,
J.Kong,
X.Wang,
W.Wei,
W.Xie,
X.F.Yu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Interferon (IFN) is a key component of the innate immune response to exogenous
pathogens. Interferon increases the mRNA levels of interferon-stimulated genes
(ISGs) in vivo, which is thought to account for its antiviral activity. Recent
studies have indicated that human myxovirus resistance protein 2 (Mx2 or MxB),
one of these ISGs, contributes to the inhibition of HIV-1 replication by
interferon. MxB may bind to HIV-1 relatively late in the post-entry phase, and
it leads to a reduced level of integrated viral DNA, thereby restricting HIV-1
infection. The N-terminal 91-aa domain of MxB and the assembly of MxB mediated
by the Stalk domain have also been shown to be indispensible for MxB's
anti-viral functions, but the mechanism involved has remained elusive. Here, we
report the crystal structure (2.9Å) of the human MxB Stalk domain. MxB Stalk
shows one dimer in the asymmetric unit. Each monomer contains a four-helix
bundle. Interestingly, analyses of MxB dimer interfaces show that the majority
of residues involved in the interface are not conserved between MxB and MxA,
contributing to the building of a more stable MxB dimer. MxA and MxB Stalk
domains share 46.7% sequence identity, and the structure of the MxA Stalk domain
and the overall structure of MxB Stalk have a similar conformation. Our results
indicate that although human Mx proteins share common structural
characteristics, their dimerization strategies are unique, contributing to their
unique contributions to viral restriction.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|